US Patent 7151089 Nucleoside compounds for treating viral infections
Patent 7151089 was granted and assigned to Genelabs Technologies on December, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+216 characters)
Article
Patent abstract
Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus. Such compounds are represented by Formula I as follows:
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07151089 Nucleoside compounds for treating viral infections US Patent 7151089 Nucleoside compounds for treating viral infections
Infobox
Patent Number
0715108900
Patent Number
715108900
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071510890
Date of Patent
December 19, 2006
0Patent Application Number
108612190
Date Filed
June 4, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071510890
Date of Patent
December 19, 2006
0Patent Application Number
108612190
Date Filed
June 4, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07151089 Nucleoside compounds for treating viral infections
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07151089
Date of patent
December 19, 2006
Patent application number
10861219
Date Filed
June 4, 2004
Patent primary examiner
Find more entities like US Patent 7151089 Nucleoside compounds for treating viral infections
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
